- Home
- CELU vs PETS Comparison
CELU vs PETS Comparison
Compare CELU & PETS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CELU
- PETS
- Stock Information
- Founded
- CELU 2016
- PETS 1996
- Country
- CELU United States
- PETS United States
- Employees
- CELU N/A
- PETS N/A
- Industry
- CELU Biotechnology: Pharmaceutical Preparations
- PETS Retail-Drug Stores and Proprietary Stores
- Sector
- CELU Health Care
- PETS Consumer Staples
- Exchange
- CELU Nasdaq
- PETS Nasdaq
- Market Cap
- CELU 64.3M
- PETS 58.9M
- IPO Year
- CELU N/A
- PETS N/A
- Fundamental
- Price
- CELU $2.15
- PETS $2.78
- Analyst Decision
- CELU Strong Buy
- PETS Sell
- Analyst Count
- CELU 1
- PETS 1
- Target Price
- CELU $6.00
- PETS $3.20
- AVG Volume (30 Days)
- CELU 136.2K
- PETS 91.8K
- Earning Date
- CELU 08-29-2025
- PETS 11-05-2025
- Dividend Yield
- CELU N/A
- PETS N/A
- EPS Growth
- CELU N/A
- PETS N/A
- EPS
- CELU N/A
- PETS 0.02
- Revenue
- CELU $44,590,000.00
- PETS $247,010,000.00
- Revenue This Year
- CELU N/A
- PETS N/A
- Revenue Next Year
- CELU $76.00
- PETS N/A
- P/E Ratio
- CELU N/A
- PETS $165.26
- Revenue Growth
- CELU 4.45
- PETS N/A
- 52 Week Low
- CELU $1.00
- PETS $2.72
- 52 Week High
- CELU $5.22
- PETS $6.85
- Technical
- Relative Strength Index (RSI)
- CELU 34.61
- PETS 36.96
- Support Level
- CELU $2.05
- PETS $2.98
- Resistance Level
- CELU $2.41
- PETS $2.91
- Average True Range (ATR)
- CELU 0.30
- PETS 0.11
- MACD
- CELU -0.10
- PETS -0.01
- Stochastic Oscillator
- CELU 6.57
- PETS 13.04
About CELU Celularity Inc.
Celularity Inc is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies including genetically modified and unmodified NK cells, engineered T cells including CAR-T cells, and mesenchymal-like adherent stromal cells, targeting indications across cancer, immunologic, infectious, and degenerative diseases. It manages its operations through an evaluation of three distinct business segments which include Cell Therapy, Degenerative Disease, and bio-banking. The company generates the majority of its revenue from the bio-banking segment.
About PETS PetMed Express Inc.
PetMed Express Inc along with its subsidiaries is a nationwide pet pharmacy. The company markets prescription and non-prescription pet medications, health products, and supplies for dogs and cats, direct to the consumer. The company generates its revenue by selling pet medications and pet supplies mainly to retail consumers.